|1.||Ralph, David J: 2 articles (09/2008 - 09/2008)|
|2.||Minhas, Suks: 2 articles (09/2008 - 09/2008)|
|3.||Muneer, Asif: 2 articles (09/2008 - 09/2008)|
|4.||LeMarec, Herve: 2 articles (04/2005 - 02/2005)|
|5.||Brugada, Pedro: 2 articles (04/2005 - 02/2005)|
|6.||Perez Riera, Andres Ricardo: 2 articles (04/2005 - 02/2005)|
|7.||Tan, Hanno: 2 articles (04/2005 - 02/2005)|
|8.||Borggrefe, Martin: 2 articles (04/2005 - 02/2005)|
|9.||Brugada, Ramon: 2 articles (04/2005 - 02/2005)|
|10.||Wilde, Arthur: 2 articles (04/2005 - 02/2005)|
|1.||Orthostatic Hypotension (Postural Hypotension)
06/01/1988 - "The therapeutic efficacy of midodrine, an alpha-adrenergic agonist that does not cross the blood-brain barrier, was investigated in a double-blind crossover trial in seven patients with orthostatic hypotension due to autonomic failure. "
02/01/2000 - "Midodrine (ProAmatine), an alpha-adrenergic agonist, was approved for the treatment of symptomatic orthostatic hypotension in the US. "
06/01/1988 - "Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine)."
05/01/2000 - "Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension."
02/01/1998 - "The purpose of this study was to compare two treatments for orthostatic hypotension, midodrine (an alpha adrenergic agonist), and octreotide (an SRIH analogue) to each other and to combination therapy. "
08/01/1993 - "Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope."
08/01/1993 - "The purpose of our study was to determine whether alpha-adrenergic agonist therapy could prevent neurocardiogenic syncope in pediatric patients. "
06/01/1999 - "However, based on currently available data, the pharmacologic agents most likely to be effective in the treatment of patients with vasovagal syncope include beta blockers, fludrocortisone, and alpha-adrenergic agonists. "
|3.||Heart Arrest (Cardiac Arrest)
01/01/1990 - "A number of studies have suggested that following a prolonged cardiopulmonary arrest, large doses of alpha-adrenergic agonists that possess post-synaptic alpha-2 agonist properties, i.e. "
10/01/1988 - "Although experimental data suggest that a pure alpha-adrenergic agonist may be beneficial in a cardiac arrest, recent data show that epinephrine remains the drug of choice. "
11/15/1995 - "When the duration of untreated cardiac arrest was increased from 4 to 8 minutes, the severity of postresuscitation left ventricular dysfunction was magnified, but disproportionate decreases in postresuscitation survival were again observed with placebo and epinephrine when compared with alpha-adrenergic agonists. "
12/01/1989 - "Previous studies have indicated that methoxamine (an alpha adrenergic receptor agonist) may provide an advantage compared to epinephrine (a mixed alpha and beta adrenergic agonist) during cardiac arrest and CPR. "
01/01/2003 - "In this context, some studies in experimental animals and humans have documented that hypoxia can reduce the vasoconstrictor responses to sympathetic nerve stimulation, as well as exogenous alpha-adrenergic agonist administration (functional sympatholysis). "
01/01/1994 - "The inability of alpha-stimulation to induce a tonic contraction of corporal smooth muscle under anoxia in vitro parallels the failure of penile injection of alpha-adrenergic agonists to relax ischemic priapism."
01/01/1994 - "3) Under anoxic conditions alpha-adrenergic agonists produced poorly sustained phasic contractile responses; anoxia eliminated tonic contractile responses to phenylephrine. "
01/01/2005 - "This indicates that following reversal of hypoxia, acidosis and glucopenia, failure of conventional alpha-adrenergic agonists to produce tumescence in low flow priapism is associated with irreversible smooth muscle cell dysfunction, which is linked to ATP reduction and smooth muscle cell death."
01/01/1990 - "The results of this double-blind, randomized trial demonstrate that the alpha-adrenergic agonist oxymetazoline is as effective as cocaine, and more effective than lidocaine with epinephrine, for the prevention of epistaxis associated with nasotracheal intubation."
01/01/1990 - "The alpha-adrenergic agonist oxymetazoline was compared to cocaine and to lidocaine with epinephrine with respect to prevention of epistaxis on nasotracheal intubation. "
|5.||Cocaine (Cocaine HCl)
|1.||Renal Dialysis (Hemodialysis)
|2.||Cardiopulmonary Resuscitation (CPR)
|3.||Drug Therapy (Chemotherapy)